Thursday - April 25, 2024

Category Archives: Europe

MULTIPLE SCLEROSIS MARKET OUTLOOK 2032 | Immune Response BioPharma Inc., Clene Nanomedicine, Sanofi, Merck Healthcare KGaA, TG Therapeutics, Inc., Apimeds Inc., Bayer HealthCare, Novartis, Biogen, Alk

MULTIPLE SCLEROSIS MARKET The Multiple Sclerosis Market is expected to strengthen as awareness of the disease increases and more effective interventions are being developed. The Multiple Sclerosis (MS) market dynamics are anticipated to change in the coming years owing to … Continue reading →

Dermatomyositis Market Outlook 2032 | Priovant Therapeutics, CSL Behring, Alexion Pharmaceuticals, AstraZeneca, Argenx, Pfizer, Janssen

Dermatomyositis Market Nonpharmacological therapies, like exercise and physical therapy, are essential to managing dermatomyositis. It helps improve muscle strength, mobility, and function. DelveInsight’s “Dermatomyositis Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical … Continue reading →

Duchenne Muscular Dystrophy Clinical Trial Updates 2024 | FDA Approvals, Therapies in Focus | Vyondys 53 (Golodirsen), Emflaza, Exondys 51, Translarna, Amondys 45, Viltepso, PF-06939926, Vamorolone

Duchenne Muscular Dystrophy Pipeline Insight Several major pharma and biotech companies such as Sarepta Therapeutics, PTC Therapeutics, Nippon Shinyaku, Pfizer, Santhera Pharmaceuticals/ReveraGen BioPharma, Taiho Pharmaceutical, FibroGen, Capricor, Daiichi Sankyo, Italfarmaco, Antisense Therapeutics, Solid Biosciences, among others, are actively working in … Continue reading →

Acute Myeloid Leukemia Market Outlook 2032 | Pfizer, Bristol Myers Squibb, Agios Pharmaceuticals, Abbvie, Jazz Pharmaceuticals, Astellas Pharma, Pfizer, Novartis Oncology, Daiichi Sankyo

Acute Myeloid Leukemia Market Acute Myeloid Leukemia Market has a promising outlook, with several emerging therapies in various stages of clinical development. The overall dynamics of the Acute Myeloid Leukemia market are anticipated to change in the coming years owing … Continue reading →

Multiple System Atrophy Market Outlook 2032 | H Lundbeck A/S, Theravance Biopharma, Brain Neurotherapy Bio, Inc, Ionis Pharmaceuticals, Inc., Alterity Therapeutics

Multiple System Atrophy Market Outlook 2032 In 2022, the market size of Multiple System Atrophy was highest in the US among the 7MM accounting for approximately USD 131 million that is further expected to increase by 2032. The Multiple System … Continue reading →

Cervical Dystonia Pipeline Assessment, 2024 | In-depth Insights Into the Emerging Drugs, Latest FDA Approvals, Clinical Trials, Therapies, Key Companies

Cervical Dystonia Pipeline Insight “Cervical Dystonia Pipeline Insight, 2024” report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Cervical Dystonia market. A detailed picture of the Cervical Dystonia pipeline landscape is provided, which … Continue reading →

Bipolar Disorder Pipeline Assessment, 2024 | In-depth Insights Into the Emerging Drugs, Latest FDA Approvals, Clinical Trials, Therapies, Key Companies

Bipolar Disorder Pipeline Insights DelveInsight’s, “Bipolar Disorder – Pipeline Insight, 2024,” report provides comprehensive insights about 22+ companies and 22+ pipeline drugs in Bipolar Disorder pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading →